Quantitative glucose and lactate metabolism was assessed in continuously perfused organotypic hippocampal slices under control conditions and during exposure to glutamate and drugs that interfere with aerobic and anaerobic metabolism. On-line detection was possible with a system based on slow perfusion rates, a half-open (medium/air interface) tissue chamber and a flow-injection analytic system equipped with biosensors for glucose and lactate. Under basal conditions about 50% of consumed glucose is converted to lactate in hippocampal slice cultures. Using medium containing lactate (5 mM) instead of glucose (5 mM) significant lactate uptake was observed, but this uptake was less than the net uptake of lactate equivalents in glucose containing medium. Glucose deprivation experiments suggested lactate efflux from glycogen stores. The effects of drugs compromising or stimulating energy metabolism, i.e. 2-deoxyglucose, 3-nitropropionic acid, α-cyano-4-hydroxycinnamate, L-glutamate, D-asparate, ouabain and monensin were tested in this flow-system. The data show that maintaining Na + and K + gradients consumes much of the energy, but do not support the hypothesis that L-glutamate stimulates glycolysis in hippocampal slice cultures.
INTRODUCTION
The brain is a highly energy-demanding organ and it has been generally accepted that physiological brain stimulation increases the brain's energy demand, which can be detected in vivo by various brain imaging techniques (2-[
18 F]-deoxyglucose PET, [ 15 O 2 ]-PET, fMRI etc.) In recent years, however, conflicting reports have appeared on glucose and lactate metabolism during brain activation and the possible role of lactate as a neuronal energy substrate (Chih et al., 2001; Dienel and Hertz, 2001; Gjedde et al., 2002; . Glutamate is the major excitatory transmitter of the brain and glutamatergic neurotransmission, including astrocyte-neuron glutamate recycling, is thought to be tightly coupled to energy metabolism. Some recent in vitro studies have suggested that glial glutamate uptake, which is Na + -dependent, stimulates the Na + /K + -ATPase and thereby glycolysis in astrocytes. This process causes astrocytes to release lactate, which is subsequently accumulated in neurons and used aerobically Poitry et al., 2000; Schurr et al., 1999) . However, other in vitro studies (Dienel and Hertz, 2001 ) and in vivo studies (Gjedde and Marrett, 2001) do not support the astrocyte-neuronal lactate-shuttle hypothesis.
Glucose and lactate monitoring in the brain of stroke, head-trauma, or subarachnoid hemorrhage patients has become a diagnostic tool to detect ischemic events and monitor therapeutic interventions (Hutchinson et al., 2000; Persson et al., 1996; Schulz et al., 2000) In such clinical microdialysis studies high lactate levels are often associated with poor outcome. However, neuroprotective effects of lactate have been reported in vitro using acute hippocampal slices (Schurr et al., 1988 (Schurr et al., , 1997a or organotypic hippocampal slice cultures (Cater et al., 2001 ) and, recently, also in some in vivo studies (Chen et al., 2000; Rice et al., 2002) . Biosensor-based techniques for monitoring cerebral glucose and/or lactate metabolism have been applied in vivo using intracerebral sampling by microdialysis (Jones et al., 2000) (Fray et al., 1996 (Fray et al., , 1997 or intra-arterial and intravenous sampling by ultrafiltration (Leegsma-Vogt et al., 2001) coupled to flow-injection analysis or using implanted glucose or lactate biosensors (Hu and Wilson, 1997a,b; Lowry et al., 1998) . Here we addressed some basic aspects of brain energy metabolism and effects of drugs on glucose and lactate metabolism in organotypic hippocampal slice cultures using biosensor technology. Slice cultures may represent an ideal in-vitro system in which to study substrate consumption and trafficking since they offer conditions where astrocyte neuronal coupling is minimally disturbed during the explantation procedure, unlike, for instance, reaggregated mixed neuronal/glial cultures. Because of this and because of its relatively preserved intrinsic neuronal circuitry organotypic hippocampal or corticostriatal slice cultures have become a convenient research tool to study effects of excitotoxic agents (Blaabjerg et al., 2001; Kristensen et al., 1999; Zimmer et al., 2000) , mitochondrial inhibitors Noer et al., 2002; Storgaard et al., 2000) or oxygenglucose deprivation (Bernaudin et al., 1998; Bonde et al., 2002; Newell et al., 1995; Pringle et al., 1997) . Additional advantages of this in vitro preparation, in contrast to acute slices, are that the tissue is in a stable condition at the start of the experiment. We used a continuous micro-perfusion system that allowed easy transfer of membrane inserts with interface cultures from the tissue culture plate to the perfusion device for glucose and lactate monitoring. A preliminary account of the monitoring technique for brain slice cultures was presented at the 5th International Conference on Brain Energy Metabolism in Trondheim, Norway, may 19-22, 2001 .
METHODS

Organotypic hippocampal slice cultures
Organotypic hippocampal slice cultures were prepared from locally-bred Wistar rats at postnatal day 7 and grown by the static-interface culture method, essentially as described previously Stoppini et al., 1991) . In this study we cultured the slices individually, on 12 mm semiporous membrane inserts in a 24-well culture tray (Corning Costar, Corning, NY, USA). After 3-4 days in vitro, culture medium, composed of 50% Opti-MEM , 25% horse serum and 25% Hanks balanced salt solution (HBSS) (all from Gibco Brl, Life Technologies Ltd., Paisley, Scotland) supplemented by D-glucose (25 mM final concentration, Merck, Darmstadt, Germany) was replaced by chemically defined, serum-free Neurobasal medium (Gibco Brl) with a glucose concentration of 25 mM and supplemented with glutamine (1 mM, Sigma, Vallensbaek Strand, Denmark) and 2% B27 supplement (Gibco Brl.) . This medium was replaced twice a week. After 3-4 weeks growth and maturation in this medium, the slice culture was transferred to the perfusion device for monitoring of glucose and lactate. One day before the monitoring experiment, the medium was replaced by Neurobasal medium containing 5 mM glucose (this medium was prepared by adding the appropriate amount of D-glucose to glucose-free Neurobsal medium (Gibco Brl)).
Tissue chamber for slice cultures
A Harvard 22 syringe pump (Harvard Apparatus, South Natick, MA, USA) maintained a pre-set flow of medium (0.5 to 1 µl/min) through a microperfusion chamber which via a membrane is in direct contact with the slice culture. This chamber consisted of a plastic holder (forming the floor), a 50 µm thick spacer with a diamond-shaped hole, an inlet and an outlet at the outer corners of the diamond-shaped space and the semiporous membrane of a Millicell culture plate insert (Millicell CM: hydrophilic PTFE, pore size 0.4 µm, insert size 12 mm, Millipore Corp., Bedford, MA, USA) placed on top of it (see fig. 3-1) . The dead volume of this microperfusion chamber is approximately 5 µL. The membrane of the insert serves as tissue support of the slice culture and allows exchange of substrates and metabolites with the perfusion medium, whereas the top of the slice culture remains in direct contact with ambient air (or any other gas mixture). In this way each slice culture can be easily transferred from the tissue incubator to the perfusion/monitoring device on its own membrane insert. Air and medium temperature was controlled (36 o C) by the oven of the electrochemical detector.
On-line monitoring technique
On-line monitoring of glucose and lactate in the perfusate of single hippocampal slice cultures was done using enzyme-based flow-injection analysis (FIA) (figure 3-2), essentially as described (Elekes et al., 1995; Leegsma-Vogt et al., 2001) .
A carrier solution of ferrocene PBS (137 mM NaCl, 2.7 mM KCl, 8 mM Na 2 HPO 4 , 2.5 mM KH 2 PO 4 (all from Merck, Darmstadt, Germany), 0.5 mM ferrocenemonocarboxylic acid, FcA (Lancaster Synthesis, Morecambe, England), 0.1% vol. Kathon CG (Rhom and Haas, Croydon, UK) in milliQ water, adjusted to pH 7.4 with NaOH, filtered (OE66 membranefilter, 0.2 µm, Schleicher and Schuell, Dassel, Germany) and degassed with helium) was pumped (0.5 ml/min) through the glucose and lactate sensors using an HPLC pump (LC-10AD, Shimadzu, Japan). Medium samples were injected into the FIA system at preset time intervals (e.g. 1 minute) using an automatic injection Vici Cheminert C4 valve with a 20 nanoliter internal loop (Vici-Valco Instruments, Houston, USA) and split (1:1) to allow simultaneous flow of sample through the glucose and lactate sensors, which were kept at 36 o C. The sensors consisted of sandwich-type enzyme reactors, containing an oxidase (glucose oxidase, approximately 200U, EC 1.1.3.4 or lactate oxidase, approximately 10U) and horseradish peroxidase (HRP, approximately 200U, EC 1.11.1.7)(all enzymes from Roche, Mannheim, Germany) and an electrochemical flow-cell (VT03, Antec Leyden, glassy carbon working electrode kept at 0.00 mV versus Ag/AgCl reference electrode) connected to a potentiostate (Decade, Antec Leyden B.V., Zoetermeer, The Netherlands). The currents (nano-amperes) are simultaneously recorded on a doublepen recorder (BD 112, Kipp en Zonen, Zoetermeer, The Netherlands) and on a MacIntosh computer using a PowerLab/4 SP data recording unit (ADInstruments) with Chart/Peaks software (ADInstruments). (medium/air interface) slice culture perfusion chamber. The membrane serves as tissue support and allows exchange of substrates and metabolites with the perfusion medium. A cap, which is screwed on top of a holder with an inlet and an outlet, pushes a membrane insert down and seals thereby the perfusion chamber.
Experimental procedures and drugs
Perfusion/monitoring experiments were done in ambient air. In the absence of 5% CO2 Neurobasal medium rapidly becomes alkaline. Hanks balanced salt solution (HBSS, Gibco Brl) maintains neutral pH in ambient air. Therefore we used HBSS, containing 25, 10, 5, 2, 1 or 0 mM glucose or 5 mM lactate as an energy substrate, as perfusion medium. Before each slice monitoring experiment, standard curves of glucose and lactate, as well as the exact concentration of glucose or lactate in the perfusion medium were determined. The effects of perfusion flow, glucose deprivation, and drugs compromising or stimulating energy metabolism were studied. Drugs included 2-deoxyglucose (inhibitor of glycolysis, 2-DG, 5-10 mM), 3-nitropropionic acid (mitochondrial toxin, inhibits tricarboxylic acid cycle and complex II, 3NP, 5 mM), α-cyano-4-hydroxycinnamate (inhibitor of monocarboxylate transporters, 4-CIN, 0.5-2 mM), L-glutamate (0.1-10 mM), D-aspartate (1 mM), ouabain (inhibitor of Na Diagram of the on-line flow-injection analysis (FIA) of glucose and lactate from a single slice culture using slow perfusion and amperometric biosensors. An HPLC pump is used to maintain a constant flow of carrier solution through a glucose sensor and a lactate sensor. A syringe pump is used to control the flow of medium through the slice culture perfusion chamber and an automatic injection valve injects medium samples (i.e. 20 nanoliter) into the FIA system at preset time intervals (i.e. 1 minute).
Protein assay
After monitoring experiments, the slice culture was removed from its membrane and placed in 50 µl 0.1 M NaOH for protein assay according to Bradford (Bio-Rad protein assay).
Calculations
The formulas used to calculate substrate consumption (use) and percentage of aerobic metabolism were as follows:
Glucose used (nmoles/min) = flow (µl/min) *(glucose in medium before perfusion (mM) -glucose detected after perfusion (mM)).
Lactate used (nmoles/min) = flow (µl/min) *(lactate in medium (without glucose) before perfusion (mM) -lactate detected after perfusion (mM)).
Lactate output (nmoles/min) = flow (µl/min)* lactate detected (after perfusion with glucose) (mM).
Glucose equivalents converted to lactate = lactate output / 2.
As a possible indicator of aerobic glucose metabolism we calculated the "aerobic ratio" = 100%*( glucose used -lactate output/2)/glucose used.
RESULTS
Organotypic hippocampal cultures are routinely grown in medium with high glucose (25 mM) and contained on average 43 ± 3 µg protein per culture. Pre-conditioning of the hippocampal slice cultures (20-24 hr; in 5 mM glucose) was necessary to reach stable glucose consumption and lactate output within 1 hour at a flow rate of 1 µl/min. In the initial phase of the monitoring experiment often no glucose consumption was detected whereas lactate levels were very high, suggesting a significant lactate production from glycogen stores in the initial phase (data not shown). After stabilization of glucose and lactate levels in the perfusate, the "aerobic ratio" appeared to be independent of flow rates (1 or 0.5 µl/min) and revealed values of 54 ± 4 % (n=10). Figure 3-3: Quantification of mean glucose uptake, lactate output and "aerobic ratio" in the presence of 5 mM (n=6 cultures), 2 mM (n=6 cultures) or 1 mM glucose (n=4 cultures). Data are means ± SEM and expressed as nmol glucose or lactate per minute or as "aerobic ratio". Mean of glucose uptake and lactate output in 5 mM glucose medium are absolute calculated values, whereas means of the 1 mM and 2 mM glucose groups are calculated relative to each culture's baseline metabolism in 5 mM glucose (normalized data). Significant differences between the three glucose groups were observed with respect to glucose uptake and lactate output (ANOVA, p<0.001), but not with respect to the "aerobic ratio" (see Material and Methods for further details).
Glucose consumption and lactate output usually remained stable for at least 4-6 hours (the normal duration of a perfusion-monitoring experiment). These results suggest that the metabolic integrity and viability of the slice culture remain intact throughout the experiment. Addition of 2-DG (10 mM) to the perfusion medium (HBBS) rapidly inhibited lactate efflux and glucose uptake (lactate: ca. 50% of control at 15 minutes, 25% at 60 minutes, glucose uptake completely blocked within 15 minutes, at a flow rate of 0.5 µl/min). Glucose consumption and lactate production is highly dependent on medium glucose levels below 5 mM: Lower glucose levels lead to lower glucose uptake and concomitant lower lactate production. The "aerobic ratio" was not significantly altered by perfusion with lower glucose levels (figure 3-3). Perfusion with medium containing lactate (5 mM) instead of glucose (5 mM) as an energy substrate, revealed significant uptake of lactate, but this uptake was less efficient as compared to the net uptake of lactate equivalents in the presence of glucose by the same slice cultures ( figure 3-4) . The mean glucose uptake of this series of experiments (n=5) was 0.642 nmoles/min (=1.284 nmoles lactate equivalents). Subtraction of the lactate efflux (0.452 nmoles/min) in the presence of glucose yields a net uptake of 0.832 lactate equivalents, whereas the lactate uptake in glucose-free, lactate containing medium was 0.488 nmoles/min (fig 3) .
Glucose deprivation alone, without lactate replacement, caused a gradual decline of lactate efflux, which first reached levels of about 10% of baseline after ca 60 min, at a flow rate of 1 µl/min (figure 3-5). This suggests that (astroglial) glycogen stores are a significant source of lactate production in the absence of glucose. Two hours glucose deprivation, both in the presence or the absence of lactate, did not cause any significant loss of viability as assessed by the on-line monitoring of glucose consumption and lactate output following the period of glucose deprivation. The first hour following glucose deprivation, glucose uptake was significantly increased (2-3 fold) (figure 3-5). Following perfusion with a high concentration of the mitochondrial inhibitor 3-NP (5 mM) lactate efflux is increased within the first 30 minutes, whereas glucose uptake is not significantly altered (figure 3-6), which is in accordance with inhibition of oxidative metabolism. Thereafter both lactate efflux and glucose uptake decline gradually, which may indicate that the tissue is dying ( figure 3-6 ). Time (min) glucose uptake lactate efflux 
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Figure 3-7: Effect of ouabain (500 µM) and monensin (10 µM) on glucose uptake and lactate efflux in a hippocampal slice culture. Recordings of a representative experiment are shown. Similar results were obtained in 3 (monensin) or 4 (ouabain) other slice cultures.
Energy metabolism was most clearly affected by perfusions with ouabain or monensin, agents that respectively inhibit or stimulate the Na+/K+-ATPase. (see figure 3-7, for single slice recording). Mean changes of 4-5 slice cultures are shown in figure 3-8: ouabain (500 µM) reduced glucose uptake by 30% and lactate efflux by 51%, whereas monensin (10 µM) increased glucose uptake by 203% and lactate efflux by 52%. Lower concentrations of Lglutamate (100 µM) had no significant effects on glucose uptake and lactate efflux, whereas higher concentrations of L-glutamate (1-10 mM) reduced both glucose uptake and lactate efflux. Since 10 mM L-glutamate was neurotoxic in our cultures, only the effects of 1 mM glutamate -which revealed a significant 27% reduction in lactate efflux -are presented ( figure 3-8) . D-aspartate (1 mM) did not significantly affect either glucose uptake or lacatate efflux ( figure 3-8) . Finally, we investigated the effect of 4-CIN, an inhibitor of monocarboxylate transporters, on energy metabolism: glucose uptake increased by 75% and lactate efflux by 51% using 2 mM ( figure 3-8) ; 500 µM 4-CIN caused lower, but still significant increases. The changes by 4-CIN could be reversed by changing to control medium (data not shown).
DISCUSSION
In vitro or in vivo estimates of brain energy metabolism have provided different results (Whittingham et al., 1984) . Under resting conditions in vivo, 90-95% or more of glucose is converted aerobically (Linde et al., 1999; Madsen et al., 1998) . In acute brain slices glycolysis is reduced by 50% as compared to in vivo estimates (Benjamin and Verjee, 1980; Ghajar et al., 1982; Rolleston and Newsholme, 1967) and lactate production is enhanced as compared to intact brain (Ghajar et al., 1982; Norberg and Siesjo, 1975; Whittingham et al., 1984) . Glucose metabolism and lactate production have not been studied before in cultured brain slices. However, it has been reported that LDH isozymes in ; n=3) , ouabain (500 µM; n=5), monensin (10 µM, n=4 for lactate, n=2 for glucose) and 4-CIN (2 mM, n=8) on glucose uptake and lactate efflux as compared to each culture's own baseline levels. Data are mean ± SEM. 100% for controls represent 0.53 nmoles/min glucose uptake and 0.70 nmoles/min lactate efflux. *) p<0.05; **) p<0.01, Walsh-test (changes versus own baseline).
slice cultures, just like in primary cell cultures, do not fully differentiate into the aerobic form, as occurs in vivo (Schousboe et al., 1993) . Consequently, the maximum percentage of aerobic metabolism in such cultures will be lower than in vivo. Furthermore, in cultured brain slices the glia/neuron ratio is much higher than in vivo or in acute slices. In vitro studies using primary cell cultures have shown that astrocytes release far more lactate into the medium than neurons (Walz and Mukerji, 1988) and that L-lactate can be taken up and metabolized by both neurons (Dringen et al., 1993b; Waagepetersen et al., 1998) and astrocytes (Dienel and Hertz, 2001) . In hippocampal slice cultures, we measured a glucose uptake of about 10 nmoles/min/mg protein in the presence of 5 mM glucose. In vivo glucose utilization has been estimated in rat brain using the 2-deoxyglucose labeling technique (Duelli et al., 2000; Horinaka et al., 1997; Mies et al., 1990) , or the Kety-Schmidt technique (Linde et al., 1999; Madsen et al., 1998) and revealed values of 62-72 µmol/min/100 g brain. Assuming a protein content of about 10% of wet weight, yields values of 6-7 nmoles/min/mg protein. In vitro studies using [U-
14 C]-glucose have shown higher glucose uptake in cultured astrocytes, i.e. 18 nmoles/min/mg protein, than in cultured neurons, i. e. 4 nmoles/min/mg protein (McKenna et al., 2001) . Thus the measured glucose uptake in slice cultures is slightly higher than measured in vivo, but in between the values obtained for primary cell cultures of astrocytes or neurons. Long-term (measured over a period of 60 minutes) lactate uptake is governed by metabolism and in the present study using slice cultures we measured a less efficient lactate uptake as compared to glucose uptake (in terms of net uptake of lactate equivalents). This is in line with other studies stating lower rates of lactate oxidation as compared to glucose oxidation (Dienel and Hertz, 2001 ). Under physiological conditions in vivo, [3-
13 C]-lactate is almost exclusively metabolized by neurons (Hassel and Brathe, 2000; Qu et al., 2000) . In the present in vitro study, however, lactate uptake experiments were performed in the absence of glucose and under these conditions not only neurons (via the monocarboxylate transporter, MCT2), but also astrocytes take up lactate (via the monocarboxylate transporter, MCT1), since extracellular lactate concentrations are higher than intracellular concentrations.
The glucose deprivation and 2-DG experiments indicate that a major part of the detected lactate is derived from glucose in the perfusion medium. That astroglial glycogen stores contribute to lactate efflux, is suggested by the substantial lactate efflux within the first 60 minutes following glucose deprivation. Enhanced glucose uptake following the first hour of glucose deprivation may be due to replenishment of the glycogen stores (Dringen et al., 1993a) . A previous study has also shown that organotypic hippocampal slice cultures are relatively resistant against glucose deprivation, which may be due to its high glycogen content (Cater et al., 2001 ).
To calculate the "aerobic ratio" (mean 54%), we assumed that almost all of the glucose taken up by the slice culture is metabolized via glycolysis and that the resulting pyruvate is further metabolized aerobically via the TCA cycle or anaerobically converted to lactate. Theoretically, some glucose may also be metabolized via the pentose phosphate pathway, but this accounts only for a relatively small part of glucose consumption in the brain (2-8%, Ben-Yoseph et al., 1995 and references therein) . Furthermore, TCA intermediates are important for amino acid synthesis, including glutamate, but under steady state conditions the percentage of glucose uptake used for this purpose is very small as compared to that used for energy metabolism. In vivo data suggest that only 3% of energy expenditure is used for glutamate cycling (Attwell and Laughlin, 2001) . Another factor that we have neglected in calculation of the "aerobic ratio" is that a minor part of the formed pyruvate may have been converted to alanine, instead of lactate.
It has been suggested that glucose, taken up by astrocytes, is released as lactate, which is then subsequently taken up by neurons as an energy substrate . Due to our constant perfusion system, it is likely that the recapture of lactate in vitro is less than under in vivo conditions, thus, an apparent higher rate of lactate efflux may be observed. At a constant perfusion flow, the amount of lactate released into the medium was dependent on the amount of glucose present in the medium. The more glucose available for the culture to metabolize, the more lactate is released. We would expect that a decreased availability of glucose, would cause a shift towards more aerobic metabolism. However, within the tested range (glucose levels down to 1mM), the small increase in "aerobic ratio" was not significant. Apparently, under these conditions the slice culture decreases its metabolism when faced with diminished glucose availability. This is unlike the in vivo situation, where cerebral glucose utilization is almost stable at plasma glucose concentrations ranging from 2.4 (hypoglycemic) to 30 mM (hyperglycemic), which may correspond to extracellular brain levels of about 0.5 to 5 mM glucose (Orzi et al., 1988; Suda et al., 1990) . Growing the slice cultures in hyperglycemic medium (25 mM), which is common practice, may have caused changes in the affinities of glycolytic enzymes.
Perfusion with a relatively high concentration of the mitochondrial inhibitor 3-NP (5 mM) caused -as expected -an initial rise in lactate within 30 minutes and thereafter a gradual reduction of both glucose uptake and lactate efflux, which may indicate cellular dysfunction and/or death. In previous studies using corticostriatal and hippocampal slice cultures we observed neurotoxic effects and increased glucose utilization by 3-NP at 50-100 µM after 24 hours exposure (Noer et al., 2002; Storgaard et al., 2000) . However, we did not observe significant glucose or lactate changes by 100 µM 3-NP within two hours using the perfusion-monitoring system. Possibly, effects of lower 3-NP concentrations require longer exposure times.
The experiments with the Na + /K + ATPase inhibitor ouabain indicate that a major part of energy consumption by hippocampal slice cultures is used to maintain Na + and K + gradients across neuronal and astroglial membranes. In addition, perfusion with monensin, a Na + ionophore which raises intracellular [Na + ] and thereby stimulates the Na + /K + ATPase, dramatically increased glucose uptake and lactate production. These results with ouabain and monensin in slice cultures are perfectly in line with other studies using [ 14 C]-deoxyglucose phosphorylation in astrocyte cultures (Takahashi et al., 1995) . Several other in vivo and brain slice studies have shown that blocking the Na + /K + pump approximately halves the energy usage (for review see Attwell and Laughlin, 2001 ).
It had been suggested that astroglial L-glutamate uptake stimulates glycolysis, since Lglutamate uptake is Na + -dependent, which again depends on Na + /K + -ATPase mediated extrusion of Na + (Pellerin and Magistretti, 1994; Sokoloff et al., 1996) . However, perfusion experiments with L-glutamate did not reveal the expected effects, i. e. increased glucose uptake and lactate efflux. In hippocampal slice cultures, which contain neurons and astrocytes in a later phase of brain maturation than primary cell cultures, we observed the opposite: reductions in glucose consumption (although not significant) and lactate efflux (significant as compared to baseline and as compared to D-aspartate). D-aspartate (1 mM), which is transported by the same carrier but can not be metabolized, was tested in the same slice cultures and did not cause a significant effect on lactate efflux. Thus our data do not support the hypothesis that glutamate stimulates glycolysis, but, instead suggest that glutamate may serve as an energy substrate in astrocytes, thereby causing lower glucose consumption and lactate production. Support for this concept has recently been reported by others (Dienel and Hertz, 2001 and references therein).
With glucose as an energy substrate in the medium and 4-CIN present as monocarboxylate transport inhibitor, glucose uptake and lactate efflux were significantly increased. These results suggest indeed that (part of) the (re-)uptake and metabolism of lactate was blocked and, moreover, that these effects are probably due to inhibition of the neuronal lactate transporter, which imports lactate, and not to inhibition of the glial transporter, which exports lactate under normal conditions and imports it during glucose deprivation. This is in accordance with other reports suggesting that 4-CIN has a higher affinity for the neuronal MCT2 than the glial MCT1 (Phillis et al., 2001; McKenna et al., 2001) . The increased glucose consumption observed in the presence of 4-CIN is probably not only due to inhibition of neuronal lactate uptake, but may also be explained by an effect of 4-CIN on the mitochondrial pyruvate transporter (Zeevalk and Nicklas, 2000) . It has been shown that 4-CIN decreases oxidative metabolism of pyruvate derived from glucose as well as lactate (McKenna et al., 2001 ). This may diminish mitochondrial ATP production and thereby stimulate glycolysis and glucose uptake in both neurons and astrocytes.
In summary, the present study using microperfusion of hippocampal slice cultures and online monitoring of glucose and lactate with biosensors demonstrated: (a) both lactate release and lactate re-uptake under basal conditions (4-CIN experiments in presence of glucose), (b) that lactate uptake (in the absence of glucose) is less efficient than glucose uptake, (c) that maintaining Na + and K + gradients consumes much of the energy and is linked to glycolysis (ouabain and monensin experiments) and (d) that L-glutamate does not stimulate glycolysis.
